Dong Sung Bio Pharm Co., Ltd. – FDA Inspection, Sep 8, 2017

Record Details

This FDA Inspection record concerns Dong Sung Bio Pharm Co., Ltd., with an inspection on September 8, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Dong Sung Bio Pharm Co., Ltd.
Inspection Date: September 8, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Daveta L. Bailey (Company Rep)

View Company Profile

ID · d3fb5913-34cd-47e2-8ac8-5715824f8ad9

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1027344
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dong Sung Bio Pharm Co., Ltd.

FDA Inspection

Dong Sung Bio Pharm Co., Ltd.September 8, 2017